Entero Healthcare Solutions Limited IPO: An Overview and Corporate Insight
Established in 2018, Entero Healthcare Solutions Limited operates as a healthcare product distributor in India, utilising a technology-centric platform to extend its services to pharmacies, hospitals, and clinics nationwide.
Throughout the fiscal years 2021, 2022, and 2023, the company catered to increasing numbers of retail and hospital customers, with figures surpassing 39,500, 64,200, and 81,400 for retail customers and exceeding 1,600, 2,500, and 3,400 for hospital customers during the respective periods.
Entero Healthcare Solutions boasts partnerships with more than 1,900 healthcare product manufacturers, facilitating access to an extensive inventory of over 64,500 product stock-keeping units by March 31, 2023.Operating across 73 warehouses located in 37 cities within 19 states and union territories, the company’s expansive reach serves over 81,400 pharmacies and 3,400 hospitals across 495 districts as of March 31, 2023, thereby ensuring robust connectivity with healthcare product manufacturers.
Grey Market Premium Analysis and IPO Timelines – Entero Healthcare Solutions IPO
|
Date |
GMP |
| February 09 | ₹118 |
| February 08 | ₹118 |
| February 07 | ₹125 |
Based on the price band of ₹1258.00, the estimated listing price for Entero Healthcare Solutions IPO is ₹1376.00, calculated as the cap price plus today’s Grey Market Premium (GMP). With this estimation, the expected percentage gain/loss per share is approximately 9.38%.
Pricing Details and Lot Size – Entero Healthcare Solutions Limited IPO
The price band for Entero Healthcare Solutions IPO is ₹1195 to ₹1258 per share.
Book-Running Lead Managers and Registrar – Entero Healthcare Solutions Limited IPO
ICICI Securities, DAM Capital Advisors (IDFC Securities), Jefferies India, JM Financial and SBI Capital Markets are the joint Book Running Lead Managers (BRLMs) to the issue.
Offer for Sale and IPO Size Breakdown – Entero Healthcare Solutions Limited IPO
Entero Healthcare Solutions is gearing up for its Initial Public Offering (IPO), aiming to raise Rs 1,600.00 crores. The IPO consists of a fresh issue of 0.79 crore shares valued at Rs 1,000.00 crores and an offer for sale of 0.48 crore shares worth Rs 600.00 crores.
IPO Price Band and Lot Size –Entero Healthcare Solutions Limited IPO
The price band for the Entero Healthcare Solutions IPO ranges from ₹1195 to ₹1258 per share, with a minimum lot size of 11 shares. Retail investors are required to invest a minimum of ₹13,838, while the minimum lot size investments for sNII and bNII stand at 15 lots (165 shares) and 73 lots (803 shares), amounting to ₹207,570 and ₹1,010,174, respectively.
IPO Timelines at a Glance – Entero Healthcare Solutions Limited IPO
| Event | Date |
| IPO Opening Date | February 9,2024 |
| IPO Closing Date | February 13, 2024 |
| IPO Allotment Date | February 14, 2024 |
| Initiation of Refunds | February 15, 2024 |
| Credit of Shares to Demat | February 15, 2024 |
| IPO Listing Date | February 16, 2024 |
Utilisation of Fresh Issuance and Technological Advancements – Entero Healthcare Solutions Limited IPO
The company intends to utilize the net proceeds from the fresh issue for the following purposes:
- Repayment or prepayment, either wholly or partially, of specific borrowings obtained by the company and its subsidiaries.
- Financing the long-term working capital needs of the business.
- Pursuing growth opportunities through acquisitions as part of its inorganic growth strategy.
- Meeting general corporate requirements.
Conclusion
The primary objective of the company is to establish a structured and technology-oriented platform for distributing healthcare products, catering to the comprehensive healthcare ecosystem across India. By adopting a nationwide strategy, the company strategically acquires and integrates smaller distributors, thereby expanding its geographic coverage and enhancing its customer base.
Frequently Asked Questions (FAQ) – Entero Healthcare Solutions Limited IPO
What does Entero Healthcare Solutions Limited Ltd. specialise in?
Entero Healthcare Solutions Limited operates as a healthcare product distributor in India, utilizing a technology-centric platform to extend its services to pharmacies, hospitals, and clinics nationwide.
What is the primary purpose of Entero Healthcare Solutions Limited’s IPO?
The primary purpose is to repay/pre-pay existing loans the company owes.
Who are the lead managers for Entero Healthcare Solutions Limited’s IPO?
ICICI Securities, DAM Capital Advisors (IDFC Securities), Jefferies India, JM Financial and SBI Capital Markets are the joint Book Running Lead Managers (BRLMs) to the issue.
How is the IPO structured in terms of new issuance and offer for sale (OFS)?
Entero Healthcare Solutions is gearing up for its Initial Public Offering (IPO), aiming to raise Rs 1,600.00 crores. The IPO consists of a fresh issue of 0.79 crore shares valued at Rs 1,000.00 crores and an offer for sale of 0.48 crore shares worth Rs 600.00 crores.
What is the lot size and minimum investment for retail investors in Entero Healthcare Solutions Limited IPO?
Retail investors are required to invest a minimum of ₹13,838, while the minimum lot size investments for sNII and bNII stand at 15 lots (165 shares) and 73 lots (803 shares), amounting to ₹207,570 and ₹1,010,174, respectively.
What is the price band for Entero Healthcare Solutions Limited IPO?
The price band for Entero Healthcare Solutions IPO is ₹1195 to ₹1258 per share.
How has the Grey Market Premium (GMP) trended for Entero Healthcare Solutions Limited IPO?
The GMP for today is Rs.118.
When does the IPO open and close for subscription?
Entero Healthcare Solutions IPO will open for subscription on February 9 and close on February 13.
When is the allotment date for Entero Healthcare Solutions Limited IPO?
The finalisation of the basis of allotment for Entero Healthcare Solutions IPO will be done on February 14 2024, and the allotted shares will be credited to investors’ demat accounts by February 15.
When is Entero Healthcare Solutions Limited expected to be listed on the stock exchanges?
The equity shares of Entero Healthcare Solutions are proposed to be listed on February 16 ,2024, on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
